Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
3MColgate-Palmolive

3M vs Colgate-Palmolive

This page compares 3M and Colgate-Palmolive, highlighting their business models, financial performance, and market context. It presents neutral, accessible information to help readers understand each ...

Why It's Moving

3M

3M Beats Earnings Expectations but Stock Dips on Soft 2026 Guidance.

  • Q4 profits topped estimates, highlighting resilience in core segments despite market headwinds.
  • 2026 profit guidance underwhelmed analysts, raising flags on growth pace and margin pressures.
  • Shares tumbled 8.3% over the past week to around $156, contrasting with a positive yearly return.
Sentiment:
🐻Bearish
Colgate-Palmolive

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

  • JPMorgan hiked its target to $93 with an Overweight rating, betting on plain-vanilla stability despite mixed U.S. consumer signals in the sector preview.
  • TD Cowen cut to $86 but held Buy, warning of a tough 2026 with weak volume growth echoing last year's -0.9% dip.
  • Ex-dividend action hit January 21, delivering $0.52 per share to holders, underscoring CL's appeal as a dividend stalwart in uncertain times.
Sentiment:
⚖️Neutral

Investment Analysis

3M

3M

MMM

Pros

  • 3M has raised its 2025 earnings outlook, reflecting improved profitability and successful execution of its turnaround strategy.
  • The company has delivered strong organic sales growth and expanded operating margins, driven by cost controls and a shift towards higher-margin products.
  • Recent settlements of long-standing legal issues have reduced uncertainty and cleared the path for future growth and investment.

Considerations

  • Despite recent gains, 3M's valuation scores only moderately on undervaluation metrics, suggesting limited upside potential for new investors.
  • The stock has experienced significant volatility, with technical forecasts indicating possible downward pressure in the near term.
  • Ongoing restructuring and product mix changes carry execution risks that could affect future performance.

Pros

  • Colgate-Palmolive maintains a strong global brand presence and consistent demand for its consumer products across multiple categories.
  • The company operates with a stable balance sheet and a history of reliable dividend payments, appealing to income-focused investors.
  • Colgate-Palmolive benefits from a diversified product portfolio, including oral care, personal care, and pet nutrition segments.

Considerations

  • Revenue growth has been relatively slow, constrained by mature markets and limited pricing power in key regions.
  • The company faces increasing competition from private labels and new entrants in the consumer goods sector.
  • Exposure to foreign exchange fluctuations and input cost volatility can impact profitability.

Related Market Insights

Reputation Shields: The Brands That Survive Any Storm

Discover 'Reputation Shields' – a Neme of crisis-proof brands with deep consumer trust. Invest in resilient companies offering consistent dividends via Nemo. Start from $1.

Author avatar

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

Patient Builders: The Steady Compounders Outpacing Market Volatility

Discover Patient Builders: companies like Microsoft, J&J, & P&G focused on sustainable long-term growth. Invest in steady compounders via fractional shares on Nemo.

Author avatar

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

3M (MMM) Next Earnings Date

3M Company's next earnings date is April 27-28, 2026, covering the first quarter of 2026 (ending March 2026). This follows their most recent Q4 2025 report released on January 20, 2026. Investors should monitor official announcements for any adjustments to this schedule.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive will report its next earnings on January 30, 2026, which is scheduled for 8:30 a.m. ET. This earnings report will cover the company's fourth quarter and full year 2025 results. Analysts are projecting earnings per share of $0.91 for the quarter, with revenues expected at $5.1 billion, representing a 3.2% year-over-year increase.

Which Baskets Do They Appear In?

Reputation Shields

Reputation Shields

Invest in companies with brands so powerful they're practically bulletproof. These carefully selected stocks represent iconic names with decades of consumer trust, giving them unique protection against scandals and market turbulence that would devastate lesser companies.

Published: June 17, 2025

Explore Basket
Patient Builders

Patient Builders

Companies that create lasting value through quality and customer trust rather than chasing quick profits. This carefully curated collection showcases market leaders who've proven that patient, sustainable growth leads to superior long-term returns.

Published: June 17, 2025

Explore Basket

Buy MMM or CL in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

3MAmbev

3M vs Ambev

3M vs Ambev: Business models and markets compared

3MKimberly-Clark

3M vs Kimberly-Clark

3M vs Kimberly-Clark: Company comparison

3MDiageo

3M vs Diageo

3M vs Diageo: stock comparison

Frequently asked questions